Global Muscle and Joint Pain Remedies Market size is estimated to be valued over XX million in 2020 and will register a CAGR of above 6.9% during the forecast period (2019-2025) to reach US$ XX million by 2025. Muslce and joint pain are highly prevalent among mid-aged adults and geriatric population. Stretch in tendons and ligaments due to improper posture causes severe pain if left untreated. Sedentary lifestyle particularly in developed region is key driving factor muscle and joint pains.

Global Muscle and Joint Pain Remedies Market – Report Taxonomy

The 2020 report edition of Muscle and Joint Pain Remedies market is analyzed on the basis of therapeutic application, prescription type, product formulation, and distribution channel.

Product Type:

• Non-Opioids
  • Non-steroidal Anti-Inflammatory Drugs (NSAIDS)
  • Methyl Salicylate
  • Capsaicin
  • Lidocaine
• Opioids

• • Buprenorphine
  • Fentanyl

Prescription Type:

• Prescription
• Over-the-Counter (OTC)

Formulation

• Cream
• Gels
• Spray
• Patch
• Others

Distribution Channel:

• Pharmacies
• Online Channels
• Hypermarket & Supermarkets
• Convenience Stores
• Drug Stores
• Hospitals
• Others

Global Muscle and Joint Pain Remedies Market Size Analysis – By Region

Globally, North America dominated the global sales. The region accounted for 36.9% share in 2019.

Asia Pacific is expected to register fastest CAGR during the forecast period. China and India are lucrative markets in the region.

Global Muscle and Joint Pain Remedies Market Competition Analysis – Key Players Assessment

Key companies operating in the industry are Reckitt Benckiser Group Plc., GlaxoSmithKline Plc., Pfizer Inc., Johnson & Johnson, Novartis AG, Sanofi S.A., Topical BioMedics, Inc., Chattem, Inc., Exzell Pharma, AdvaCare Pharma, Sun Pharmaceutical Industries Ltd., Performance Health Technologies, Inc., and Nestle.

COVID19 Impact on Global Muscle and Joint Pain Remedies Market

As per the estimates, the industry is expected to witness 23.5% decline in sales in 2020 than that in 2019. Contact Bekryl Analysts to gain in-depth insight on COVID19 impact during short term and long term projection.

What Will You Discover in the Report?

• An in-depth analysis of the Muscle and Joint Pain Remedies market across regions – North America, Latin America, Western Europe, Central and Eastern Europe, Asia Pacific, Middle East, and Africa.
• How the Muscle and Joint Pain Remedies market sales is expected to grow throughout the forecast period.
• How geopolitical policies and technological changes will affect the Muscle and Joint Pain Remedies market in near future
• Where the stakeholders should invest to generate higher profit margins
• How consumers (end-users) will reflect to the Muscle and Joint Pain Remedies industry during the forecast period
• Who are the Muscle and Joint Pain Remedies industry leaders and what are the key initiatives taken by them for long term growth

Analyst access with Bekryl Market Analysts

Purchasing of Muscle and Joint Pain Remedies market research report will give clients access to 120 minutes telephonic access with a research analyst. The duration for access to analysts will be based on the report subscription editions.

Global Baby Foods Market size is estimated to be valued over XX billion in 2020 and will register a CAGR of above 7.1% during the forecast period (2019-2025). Baby food industry is highly mature and with substantial consolidation.

Nestlé, Abbott, Mead Johnson, and Danone are global leader with Nestlé and Danone accounting for over XX% of global share. Companies has strategized their business on pricing differentiation to capture the most of the market. However, in last few year, China based players are gaining high traction and as a result leading players are facing stiff competition from regional players.  Key players are focusing on leveraging online sales channel to further consolidate the market and generate higher ROI.

The global baby market revenue witnessed sluggish growth in developed economies. However, growth is expected to be lucrative in developing regions. Various companies are engaged in awareness campaign to help healthcare personnel realize the potential and benefits of toddler foods. Leading companies employs sales force that interacts directly with doctors. Engaged players are also engaged in premium products to woo consumers in developed regions.

On a macroeconomic scenario, various health related campaigns by NGO and government organization is expected to drive the baby foods demand worldwide. Growing working personnel and long office work hour will further create value addition to the sales of baby food globally.

Global Baby Foods Market – Report Taxonomy

The 2020 report edition of Baby Foods market is analyzed on the basis of category, type and distribution channel.

Product Type:

• Conventional
• Organic

In 2019, conventional baby foods accounted for 97.2% market share. Organic foods is gaining market traction and is expected to gain 418 basis points during the forecast period.

Type:

• Milk Formula
  • Follow-on Milk Formula
  • Starting Milk Formula
  • Special Milk Formula
  • Toddler’s Milk Formula
• Dried Baby Food
• Ready-to-Feed Baby Food
• Others

Distribution Channel:

• Pharmacies
• Online Channels
• Hypermarket & Supermarkets
• Convenience Stores
• General Stores
• Drug Stores
• Specialty Outlets
• Others

Global Baby Foods Market Size Analysis – By Region

Globally, Asia Pacific will dominate the industry not only in terms of share but also growth rate. It is the only region to register double digit growth during the forecast period. China and Japan collectively accounted for over 61% of regional share.

North America baby foods market size ranked next to Asia Pacific. High disposable income, better healthcare amenities, significant monetary influx in R&D and presence of leading players has led to high penetration of infant nutrition in the region. Abbott, Nestle, Mead Johnson and DANONE accounted for over XX% of regional share in 2020.

Global Baby Foods Market Competition Analysis – Key Players Assessment

Key companies operating in the industry are Nestlé, Abbott, Mead Johnson, Danone, The Kraft Heinz Company, Beingmate Baby & Child Food Co. Ltd., Meiji Holdings Co. Ltd., Pfizer Inc., and Synutra International, Inc.

COVID19 Impact on Global Baby Foods Market

As per the estimates, the industry is expected to witness 18.9% decline in sales in 2020 than that in 2019. Leading enterprises are expected to substantially witness rise in debts and other operational expenses. The market is expected to revive by first half of 2021.

What Will You Discover in the Report?

• An in-depth analysis of the Baby Foods market across regions – North America, Latin America, Western Europe, Central and Eastern Europe, Asia Pacific, Middle East, and Africa.
• How the Baby Foods market sales is expected to grow throughout the forecast period.
• How geopolitical policies and technological changes will affect the Baby Foods market in near future
• Where the stakeholders should invest to generate higher profit margins
• How consumers (end-users) will reflect to the Baby Foods industry during the forecast period
• Who are the Baby Foods industry leaders and what are the key initiatives taken by them for long term growth

Analyst access with Bekryl Market Analysts

Purchasing of Baby Foods market research report will give clients access to 120 minutes telephonic access with a research analyst. The duration for access to analysts will be based on the report subscription editions.

Global Baby Towelette Market Size is estimated to be valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2025 during the forecast period. Rising newborn babies along with increasing consumer spending and rise in healthcare awareness is expected to create favorable market opportunity for baby towelette manufacturers. The market is highly fragmented with presence of large number of regional players. Cutthroat competition has led to series of change in market landscape. Many companies are focusing on product packaging and pricing parameters to gain market traction especially among millennials residing in Tier I and Tier II cities.

Baby Towelette Market Trends

• Baby towelette consumes nonwoven wipes 6X higher than homecare wipes. Sales of nonwoven wipes is increasing due to ease of use and cost convenience. Over-supply of high quality nonwoven will be a major challenge for industry players. Low cost production in Southeast Asia market is a major challenge for companies based in Europe.
• The industry is shifting towards environmentally sustainable products.
• Market expansion in developing regions especially India and ASEAN market. The market in still nascent in India as compared to rest of the world. While the household penetration is fairly low in India, the baby towelette market is registering double digit growth, Online channel has played a key role in overall sales of baby wipes. It has also created awareness among consumes. As such, sales is expected to witness upward trajectory growth during the forecast period.

Baby Towelette Market – Report Taxonomy

The 2020 report edition of baby towelette market is analyzed on the basis of product type, packaging type and distribution channel.

Product Type:

• Dry Wipes
• Wet Wipes

Packaging Type:

• Flow Packs
• Sachets
• Tubes

Distribution Channel:

• Pharmacies
• Online Channels
• Hypermarket & Supermarkets
• Convenience Stores
• General Stores
• Others

Global Baby Towelette Market Size Analysis – By Region

In 2019, North America baby towelette market dominated the global sales. The region accounted for 33.8% share in 2019, however, is expected to witness decline in market share by 318 basis poinst between 2019 and 2025.

Asia Pacific is expected to register fastest growth during the forecast period. China, India and Japan are estimated to collectively account for 79.8% regional share in 2020.

Global Baby Towelette Market Competition Analysis – Key Players Assessment

Procter & Gamble, Eleeo Brands, Jhonson & Jhonson, Pampers, Cotton Babies Inc, Babisil Products Ltd, The Himalaya Drug Company, Kirkland, Moony, Medline, Hengan International Group Company Ltd, Unicharm Corporation are key global players operational in the baby wipes market.

COVID19 Impact on Global Baby Towelette Market

As per the estimates, the industry is expected to witness 34.9% decline in sales in 2020 than that in 2019. Sales is however expected to quickly regain market position in first half of 2021. Contact Bekryl Analysts for deep dive analysis of COVID19 impact on the industry.

What Will You Discover in the Report?

• An in-depth analysis of the Baby Towelette market across regions – North America, Latin America, Western Europe, Central and Eastern Europe, Asia Pacific, Middle East, and Africa.
• How the Baby Towelette market sales is expected to grow throughout the forecast period.
• How geopolitical policies and technological changes will affect the Baby Towelette market in near future
• Where the stakeholders should invest to generate higher profit margins
• How consumers (end-users) will reflect to the Baby Towelette industry during the forecast period
• Who are the Baby Towelette industry leaders and what are the key initiatives taken by them for long term growth

Analyst access with Bekryl Market Analysts

Purchasing of Baby Towelette market research report will give clients access to 120 minutes telephonic access with a research analyst. The duration for access to analysts will be based on the report subscription editions.

Global Pre & Postnatal Vitamins Market Size is estimated to be valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2025 during the forecast period. The consumption of pre & postnatal vitamins has increased by 7.3% between 2015 and 2019 and is expected to further register upward trajectory growth to create higher incremental opportunity for industry players. According to the U.S. national survey, nearly 97% of gynecologists recommend women to have multivitamin, multimineral supplements (MVMM) during pregnancy. The consumption is fairly high in developed regions as compared to developing markets.

There are range of supplements available during pregnancy. Iodine, folic acid, iron, potassium, and  calcium are most commonly used supplements. Each one of them has its own importance and are recommended based on patient’s condition. For instance, while calcium helps maintain the bone density, folic acid is taken to prevent neural birth defects.

Pre & Postnatal Vitamins Market – Report Taxonomy

The 2020 report edition of Pre & Postnatal vitamins market is analyzed on the basis of product type, form type and distribution channel.

Product Type:

• Prenatal Vitamins
• Postnatal Vitamins

In 2019, prenatal vitamins market accounted for 84.8% market share. Between 2019 and 2020, the segment will create US$ XX million revenue opportunity for industry players.

Form Type:

• Tablets & Capsules
• Powders
• Gummy

In 2019, tablets & capsules based maternity vitamins accounted for 59.1% market share, followed by powders and gummy based vitamins.

Distribution Channel:

• Pharmacies
• Online Pharmacies
• Drug Stores
• Hypermarket & Supermarkets
• Convenience Stores
• Others

By distribution channel, pharmacies accounted for highest share followed by hypermarket & supermarket. Sales of pre & postnatal vitamins is expected to register double digit growth through online sales channel. In last few years, many online pharmacies backed with venture capitalists has emerged in the market. Emergence of online channel has led to many regional companies scaling revenue at minimal operational costs. As such, many enterprises are strategizing on distribution channel to expand business presence with lower overhead costs including logistic charges.

Pre & Postnatal Vitamins Market Size Analysis – By Region

In 2019,  North America dominated the global share, accounting for 37.1% market share. This is closely followed by Western Europe and Asia Pacific. Asia Pacific is expected to register fastest CAGR during the forecast period. Huge demographic population, improving healthcare infrastructure and rise in healthcare spending are few key factors expected to drive the sales of pre & post-natal vitamins in the region.

Pre & Postnatal Vitamins Market Size Analysis – Competition Landscape

Global pre & postnatal vitamins market is substantially fragmented with presence of few regional players. However, the market is highly competitive with major players expanding their business footprint through inorganic strategy. Garden of Life, Jean Coutu Group, Douglas Laboratories, NATURELO Premium Supplements, Nestlé, S.A., MegaFood, Metagenics, Nature’s Way are few key players operational in the market.

COVID19 Impact on Pre & Post Natal Vitamins Market

As per the estimates, production has declined by 27.5% in first and second quarter of 2020 due to lockdown imposition. However, the demand remains strong. As such, the market is expected to quickly recover and gain market traction in second half of 2020. Contact Bekryl Analysts to understand the COVID19 impact on the industry during short term and long term period.

What Will You Discover in the Report?

• An in-depth analysis of the Pre & postnatal vitamins market across regions – North America, Latin America, Western Europe, Central and Eastern Europe, Asia Pacific, Middle East, and Africa.
• How the Pre & postnatal vitamins market sales is expected to grow throughout the forecast period.
• How geopolitical policies and technological changes will affect the pre& postnatal vitamins market in near future
• Where the stakeholders should invest to generate higher profit margins
• How consumers (end-users) will reflect to the pre & post natal industry during the forecast period
• Who are the Prenatal and postnatal industry leaders and what are the key initiatives taken by them for long term growth

Analyst access with Bekryl Market Analysts

Purchasing of Prenatal & postnatal market research report will give clients access to 120 minutes telephonic access with a research analyst. The duration for access to analysts will be based on the report subscription editions.

Global Surgical Sutures market size is valued at US$ 2.8 billion in 2019. Sutures are strand of materials that are mainly used to close skin and tissue wounds. Placement of suture depends on the type of wound. Suture material should be of high tensile strength as well as sterile and non-allergic to patients. Various features are analyzed before putting these materials in closing the wounds. As such, there are wide range of sutures available in the market depending on the type of wound.

Companies are focusing on technology in order to strengthen their market presence in the segment. In future, surgical sutures market is set to be more consolidated with major players opting for inorganic growth strategy to generate high return on investment (ROI).

Key Trends and Factors Driving Surgical Sutures Market Demand:

• Increase in number of surgical procedure will boost the demand for surgical sutures. As per the World Health Organization (WHO), over XX surgical procedures was carried out worldwide. Developed regions accounted for the highest number of surgical procedure owing to well established healthcare infrastructure and favorable reimbursement policies. Demand for surgical sutures will rise with increase in number of surgical procedure.
• In the last few years, many hospitals and clinics has emerged worldwide to address the growing healthcare issues. Surgeries has also increased with expansion in healthcare facilities. This has positively created favorable ecosystem for sales of surgical sutures. Vendors directly collaborates with leading multinational hospitals to supply their product for long term duration, thereby minimizing any volatility in the market. The trend is quite prominent in developing regions of Asia Pacific wherein hospital chains are emerging at double digit rate, creating huge market prospects for leading players as well as new entrants.
• Free trade agreements and international cooperation in healthcare trade has also created favorable ecosystem for the companies. There are many free trade agreements among group of countries. For instance, United States-Mexico-Canada agreement (USMCA) has strengthened the free trade agreement of medical devices and further recognized the expansion of intellectual property protections in the region. The agreement not only will benefit companies to trade free across borders but also ensure intellectual property rights necessary to tackle counterfeiting products. As per the estimates, medical products market has expanded over 760% since the inception of NAFTA. The trend is likely to be same throughout the forecast period. Similar instances can be seen in other parts of world, such as EU and South Korea pact. The free trade agreement between South Korea and EU has helped medical products market to flourish. Under the agreement, Korea is expected to eliminate duties on EU medical products.
• Product launch is the key strategy adopted by surgical sutures industry players. Various major companies are launching a range of surgical sutures at low cost to meet consumer aspirations. Recently, in 2017, Mellon Medical raised US$ 6.6 million to advance its suturing technology. The company claims to suture tabular and layered structures twice as fast as conventional technique. Another company ZipLine Medical is also working in the similar field. The company is investing on its Zip Skin Closure, and claims to be three to five times faster than conventional sutures in healing wounds.

Global Surgical Sutures Market Size, Analysis across Segments:

• On the basis of product type, the industry revenue is analyzed into absorbable and non-absorbable. In 2018, absorbable sutures accounted for the highest sales. Absorbable sutures generated over USD 2.2 billion in 2018. Absorbable suture is further segmented into synthetic and natural. Synthetic accounted for 78% of total segment sales in 2018.
• On the basis of end-use, sales revenue is analyzed across hospitals, ambulatory surgical centers, and specialty clinics. Among these, majority of sutures were sold in hospitals in 2018. Presence of higher funds along with large number of patients flocking to hospitals is the key reason for overall sales in the segment. Moreover, hospitals opt for bulk orders, thereby minimizing the operational cost. Gradually, developing regions is witnessing huge number of new hospitals, along with good healthcare insurance policies. All these factors have created favorable business ecosystem in hospital end-use segment.
• On the basis of therapeutic application, the global surgical sutures market is segmented into cardiovascular, orthopedic, gynecological, and general surgeries. Among these, general surgeries accounted for the highest share in 2018. According to the estimates, large number of patients underwent general surgeries in 2018, leading to significantly higher usage of sutures globally. While general surgeries will continue to dominate the global share, cardiovascular segment is registering impressive growth owing to higher prevalence rate of cardiovascular diseases and complications arising out of the same.

Global Surgical Sutures Market Size, Regional Analysis:

Globally, North America surgical sutures market accounted for 35.0% global share in 2018. Over 45 million surgical procedures was carried out in 2017, and the number of such cases is increasing at steady rate, necessitating the need for effective treatment. Moreover, there are large number of surgical procedure carried out due to chronic illness including cardiovascular diseases and bariatric surgeries.

Asia Pacific will register fastest growth and is expected to register double digit CAGR to create high incremental revenue opportunity for industry players. Changing lifestyle has also affected Asia population thereby demanding effective treatment. Some cases need surgical procedures. China and India are the most promising countries for the industry players. These countries collectively account for over 26% of global population, thereby paving way to huge addressable revenue opportunity. Relaxation in FDI and custom duty is expected to help boost overall sales of surgical sutures by companies based in Europe and North America.

Global Surgical Sutures Market Size, Competition Landscape:

Some of the key industry players covered in the report are:

• Medtronic Plc.
• Integra LifeSciences Corp.
• Teleflex Inc.
• Smith & Nephew
• Johnson and Johnson
• Braun
• Boston Scientific
• 3M Healthcare
• Derma Sciences
• Dolphin Sutures
• Riverpoint Medical
• Lotus Surgicals

Research Scope

By Product Type:

• Absorbable Sutures
  • Synthetic Sutures
    • Polyglactin 910 Sutures
    • Poliglecaprone 25 Sutures
    • Polydioxanone Sutures
    • Polyglycolic Acid Sutures
    • Others
  • Natural Sutures
• Non Absorbable Sutures
  • Nylon Sutures
  • Stainless Steel Sutures
  • Prolene Sutures
  • Others

By End-use Channel:

• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics
• Others

By Suture Type:

• Multifilament
• Monofilament

By Therapeutic Application:

• General surgery
• Cardiovascular Surgery
• Gynecological Surgery
• Ophthalmic Surgery
• Orthopedic surgery
• Bariatric Surgery
• Cosmetics and Plastic Surgery
• Others

What Will You Discover in the Report?

• An in-depth analysis of the Surgical Sutures market across regions – North America, Latin America, Western Europe, Central and Eastern Europe, Asia Pacific, Middle East, and Africa.
• How the Surgical Sutures market sales is expected to grow throughout the forecast period.
• How geopolitical policies and technological changes will affect the Surgical Sutures market in near future
• Where the stakeholders should invest to generate higher profit margins
• How consumers (end-users) will reflect to the Surgical Sutures industry during the forecast period
• Who are the Surgical Sutures industry leaders and what are the key initiatives taken by them for long term growth

Analyst access with Bekryl Market Analysts

Purchasing of Surgical Sutures market research report will give clients access to 120 minutes telephonic access with a research analyst. The duration for access to analysts will be based on the report subscription editions.

Global Hydrocephalus Shunt market size is estimated to be valued over US$ 438 million in 2019 and is expected to register 7.3% CAGR during the forecast period. Hydrocephalus is a medical condition caused due to accumulation of fluid in the brain These shunts are medical devices that are placed inside the brain to drain out the extra cerebrospinal fluid (CSF).  These devices are highly effective and is widely preferred means of treating the patients. Over the last ten years, prevalence rate of congenital hydrocephalus has decreased to a large extent. As per the estimates, every one in 1000 births is affected with congenital hydrocephalus. Acquired hydrocephalus has also increased in recent years mainly due to changing lifestyle or illness and injuries caused to the brain. Medical industry has seen few major technological advancements that are highly effective to treat such cases. Shunting is one such procedure. Sales of ventriculoperitoneal Shunt has increased and is expected to continue its growth momentum during the forecast period.

Competition Landscape:

Hydrocephalus shunt market is highly consolidated. Only a few players are engaged in manufacturing the shunts. As a result, manufacturers have greater control on the profit margins. These players primarily focus on product development and well developed distribution channels. Partnership with regional vendors and hospitals has yielded stable growth since past many years.

In 2018, Medtronic plc, B. Braun Melsungen AG, and Integra LifeSciences Corporation accounted for over 82% of global sales revenue.

Key Trends and Factors Driving Hydrocephalus Shunt Market Demand:

• Traumatic brain injury (TBI) has been a major cause of concern for healthcare personnel. According to the American Speech Language Hearing Association, over 1.7 million TBIs are detected every year in U.S. TBI is also known as silent epidemic since it contributes to over 30% of all injury related deaths worldwide. Various studies have correlated acquired hydrocephalus prevalence due to rise in number of traumatic brain injury cases.
• Shunting manufacturers take various measures to create awareness among consumers related hydrocephalus prevalence and its potential causes. Such awareness campaign also help companies to showcase their products and reach maximum number of consumers. In addition to companies, there are various organization and NGOs that work solely on creating awareness on neurological disorders. Hydrocephalus Association is one such dedicated organization focuses on creating awareness related to hydrocephalus among common masses. Innovative campaigns and research grants has helped organization to ensure effective treatment. In 2018, the organization awarded Hydrocephalus Association (HA) Innovator Award to three scientists.
• Increase in geriatric population is another major cause of hydrocephalus. Geriatric population are more susceptible to brain injuries and other environmental factors. As a result, neurological cases are prevalent among the population. Shunting is required to ensure the people have healthy lifestyle. In 2018, hydrocephalus shunting was seen in majority of the targeted geriatric population.
• Merger and Acquisitions continues to be a key trend in hydrocephalus shunt market. Cut-throat competition and need to acquire newer technologies are key factors that led companies to opt for mergers and acquisitions. In 2017, Integra LifeSciences Corporation acquired Johnson & Johnson Codman Neurosurgery business for US$1.045 billion. Acquisition has helped Integra LifeSciences to have the broad medical device portfolios in the neurosurgery market.
• Product Development is another major hydrocephalus shunt market trend. Companies and institutes are spending heavily to launch newer products. Recently, in 2018, Rogers Research Group at Northwestern University, developed sensor that can measure temperature to determine how much fluid is flowing through a shunt in hydrocephalus patient. The technology could potentially help save. health care system millions of dollars. Similar such technologies are expected to emerge in the market in next eight to ten years.

Hydrocephalus Shunt Market Size: Segment Analysis

• On the basis of products, the industry is segmented into valves and catheters. In 2018, valves accounted for 87% of total value sales. It will continue to maintain its market share throughout the forecast period.
• On the basis of therapeutic procedure, the industry revenue is analyzed across ventriculoperitoneal, ventriculoatrial, ventriculopleural, and lumboperitoneal. Among these, ventriculoperitoneal accounted for the highest share in 2018.
• On the basis of targeted population (patients by age demographics), majority of hydrocephalus shunting was performed on pediatric population. This is because congenital hydrocephalus prevalence is high compared to acquired hydrocephalus.
• On the basis of end-use channel, hydrocephalus shunting market sales is witnessed across hospital, clinics, neuro-centers, ambulatory surgical centers, and academic & research centers among others. 88% of hydrocephalus shunting procedure was carried out in hospitals in 2018.

Global Hydrocephalus Shunt Market Size, Regional Analysis:

North America hydrocephalus shunt market accounted for 56% of global share in 2018. Growth in the region is mainly attributed to higher hydrocephalus prevalence rate along with well-developed healthcare infrastructure and favorable government reimbursement policies. The region is also characterized by presence of major companies having strong distribution channel.

Western Europe is another major market for the industry players. Almost all players have CE approval for the shunt. The region has significantly higher number of pediatric population suffering from the disease. The targeted demographic structure is also expected to increase during the forecast period, which will further demand the shunt implant in affected population group. In 2018, UK accounted for highest sales of shunt, followed by France and NORDIC.

Leading Hydrocephalus Shunt Market Players:

Some of the key industry players covered in the report are:

• Boston Neurosciences
• DePuy Synthes
• Tokibo Co., Ltd
• HLL Lifecare Limited
• Christoph Miethke GmbH & Co. KG
• Integra LifeSciences Corporation
• Sophysa SA
• Spiegelberg GmbH & Co. KG
• Terumo Corporation
• Natus Medical Incorporated
• Braun Melsungen AG
• Medtronic Plc
• Johnson & Johnson Services Inc.

Research Scope

By Product Type:

• Valves
  • Fixed Pressure Valves
  • Adjustable Pressure Valves
• Catheters
  • Standard Catheters
  • Antimicrobial Catheters

By Therapeutic Procedure:

• Ventriculoperitoneal
• Ventriculoatrial
• Ventriculopleural
• Lumboperitoneal

By Targeted Population:

• Pediatric
• Adults

By End-use Channel:

• Hospitals
• Clinics
• Neuro centers
• Ambulatory Surgical Centers
• Others

What Will You Discover in the Report?

• An in-depth analysis of the Hydrocephalus Shunt market across regions – North America, Latin America, Western Europe, Central and Eastern Europe, Asia Pacific, Middle East, and Africa.
• How the Hydrocephalus Shunt market sales is expected to grow throughout the forecast period.
• How geopolitical policies and technological changes will affect the Hydrocephalus Shunt market in near future
• Where the stakeholders should invest to generate higher profit margins
• How consumers (end-users) will reflect to the Hydrocephalus Shunt industry during the forecast period
• Who are the Hydrocephalus Shunt industry leaders and what are the key initiatives taken by them for long term growth

Analyst access with Bekryl Market Analysts

Purchasing of Hydrocephalus Shunt market research report will give clients access to 120 minutes telephonic access with a research analyst. The duration for access to analysts will be based on the report subscription editions.

Global Osteoarthritis Market size is estimated to be valued over US$ 2,205 million in 2019, registering a CAGR of 9.1% between 2019 and 2028. This amounts to 2.2X higher revenue opportunity by 2028 than that of 2018. The industry is substantially consolidated with major players focusing on R&D to launch cell mediated drugs. The industry is likely to witness major change since majority of the clinical trials are in phase III and IV.

Key Trends and Factors Driving Osteoarthritis Market Demand:

• Number of osteoarthritis cases has increased at alarming rate in last decade. As of 2019, there are over 316 million prevalent cases of OA worldwide. This is expected to increase to 381 million cases by 2028. Higher cases of OA will propel the demand for effective treatment options, that largely exists in medicated form.
• Competition in the market is expected to heighten during the later phase of forecast period (2024 onwards), since majority of the products are under trial phase II of FDA. Once approved, the industry will become highly competitive with substantial effect on market share of few major players. Close to half of the products are under phase III and IV. Majority of the clinical trials are conducted in North America followed by Western Europe. Japan and South Korea are key region in Asia Pacific wherein players are conducting clinical trials to evaluate efficacy of the products. Among major companies, Pfizer is reported to having highest number of clinical trials. The company also dominated in terms of osteoarthritis market share in 2018.
• Merger and acquisition will be one of the key trend in the market. Rise in competition will propel the companies to acquire technological and market competence of already established players. Recently, in 2018, Mundipharma entered in strategic collaboration with Kolon Life Sciences to market Invossa®-K in Saudi Arabia and United Arab Emirates. The deal was further extended to Japan. The drug was first approved in 2017 by Korean Ministry of Food and Drug Safety (MFDS) and is regarded as world’s first cell mediated gene therapy for osteoarthritis.

Global Osteoarthritis Market Size, Analysis across Segments:

• On the basis of drug class, the industry revenue is analyzed across Corticosteroids, NSIADs, and Viscosupplementation Agents. Viscosupplementation will gain highest traction in terms of growth during the forecast period.
• On the basis of route of administration, osteoarthritis drugs market revenue is analyzed across oral based drugs, parenteral drugs, and topical drugs. Among these, oral based OA drugs accounted for the highest share in 2018. The trend is likely to be same throughout the forecast period.
• On the basis of distribution channel, the industry revenue is analyzed across hospitals, drugstores, pharmacies and online channels. While online channels accounted for the lowest share, it is expected to register double digit growth during the forecast period. Major players are actively investing in online channels in order to provide ease of buying convenience to customers and thereby retaining for a longer durations.

Global Osteoarthritis Market Size, Regional Analysis:

Globally, North America witnessed the highest osteoarthritis drug sales in 2018. The region accounted for 57% of total osteoarthritis market revenue in 2018. There are over 61 million US population suffering from OA. This offers relatively higher addressable market to the industry players. Biologic analgesics is registering high sales in the U.S. Regeneron’s fasinumab, TissueGene’s Invossa, and Pfizer’s tanezumab are some of the key drugs sold in the region.

Asia Pacific will register fastest growth during the forecast period. Japan and China will hold highest OA market share in 2019. In 2018, Japan osteoarthritis market was valued at US$ 169 million. China and India are expected to register double digit growth, driven by higher healthcare FDI influx and improving healthcare amenities. Favorable reimbursement policies such as Ayushman Bharat by Government of India is expected to help reach affordable healthcare to lower income class people. Higher treatment outreach will significantly boost the treatment spending on osteoarthritis in the region.

Global Osteoarthritis Market Size, Competition Landscape:

Some of the key industry players covered in the report are:

• Pfizer
• Cara Therapeutics
• Mitsubishi Tanabe Pharma
• Ampio Pharmaceuticals
• Cellular Biomedicine Group
• Teva Pharmaceutical
• Eli Lilly
• Techfields Pharma
• Healthcare Life Sciences
• Seikagaku Corp
• Kolon Life Sciences
• Flexion Therapeutics
• Ono Pharmaceutical
• Regeneron Pharmaceuticals
• Mundipharma
• Samumed
• Centrexion Therapeutics
• TissueGene

Research Scope:

By Drug Class

• Corticosteroids
• NSIADs
• Viscosupplementation Agents

By Route of Administration:

• Oral
• Parenteral
• Topical

By Distribution Channel:

• Drugstores
• Pharmacies
• Hospital Stores
• Online Pharmacies

What Will You Discover in the Report?

• An in-depth analysis of the Osteoarthritis market across regions – North America, Latin America, Western Europe, Central and Eastern Europe, Asia Pacific, Middle East, and Africa.
• How the Osteoarthritis market sales is expected to grow throughout the forecast period.
• How geopolitical policies and technological changes will affect the Osteoarthritis market in near future
• Where the stakeholders should invest to generate higher profit margins
• How consumers (end-users) will reflect to the Osteoarthritis industry during the forecast period
• Who are the Osteoarthritis industry leaders and what are the key initiatives taken by them for long term growth

Analyst access with Bekryl Market Analysts

Purchasing of Osteoarthritis market research report will give clients access to 120 minutes telephonic access with a research analyst. The duration for access to analysts will be based on the report subscription editions.

Global Narcolepsy market size is valued at US$ 1.8 billion in 2019. Narcolepsy is basically a sleep disorder characterized by excessive sleepiness and sometimes hallucinations. The symptoms are roughly found in 1 among 2000 people. As of now, there is no cure to narcolepsy but effective medications and behavioral treatments are provided in order to boost the productive lifestyle. Various companies are investing on R&D to offer effective treatment medications. Many of these drugs are targeted towards cataplexy.

Key Trends and Factors Driving Narcolepsy Market Demand:

• Degree of competition is increasing especially in developed regions. New entrants are emerging in the narcolepsy drugs market. In August 2019, USFDA approved Harmony Biosciences’ pitolisant (Wakix) for the treatment of excessive daytime sleepiness (EDS) in adult patients. FDA approval is expected to help gain market share in U.S. narcolepsy drugs market, which is largely dominated by Xyrem, a CNS depressant by Jazz Pharmaceuticals. Contrary to Xyrem (Schedule III controlled substance), Wakix is termed to be potentially having no risk of dependence. This might help Harmony Biosciences to gain significant traction worldwide.
• Overall, the industry is highly consolidated with presence of only few players in the segment. Jazz Pharmaceuticals accounted for the highest share worldwide. In 2018, Jazz Pharmaceuticals generated US$ 1.4 Billion from sales of Xyrem.
• Higher prevalence of sleep disorders and neurological disorders is creating significant demand for narcolepsy drugs globally. According to the National Institute of Health (NIH), over 40 million Americans suffers from neurological disorders.

Global Narcolepsy Market Size, Analysis across Segments:

• On the basis of disease, the industry revenue is analyzed across narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Among these, NT1 is highly prevalent and is generally caused due to the deficiency of CNS hypocretin in the hypothalamus.
• On the basis of product type, sales revenue is analyzed across Central Nervous System Stimulants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Tricyclic Antidepressants, and Others.
• By distribution type, the industry revenue is analyzed across drugstores, pharmacy, convenience stores, hospitals, and online channels. Among these, majority of sales was through off-labeled. Drugstores accounted for 37.8% of total narcolepsy drug sales in 2018.

Global Narcolepsy Market Size, Regional Analysis:

Globally, Western Europe dominated the narcolepsy drug sales in 2018. The industry is witnessing healthy growth, higher than the region GDP growth. Increase in sales is attributed to rise in number of narcolepsy cases and good distribution network. Germany, UK and France accounted for 69% of total Western Europe narcolepsy drugs market.

North America is the next major destination for industry players. Favorable reimbursement policies has been a major driver for the drug sales in the region. In 2018, narcolepsy drug manufacturers generated US$ 477 million revenues from North America in 2018. The degree of competition is fairly high in the region with new players emerging in the market. Expected FDA approval of pipelined drugs will further add industry competition by 2028.

Global Narcolepsy Market Size, Competition Landscape:

Some of the key industry players covered in the report are:

• GSK
• Teva
• Bioproject SCR
• Taisho Pharmaceutical
• Balance Therapeutics
• Pfizer
• Theranexus
• Flamel Ireland
• NLS Pharma
• Jazz Pharmaceuticals
• Avadel Pharmaceuticals

Research Scope

By Disease Type:

• Daytime Extreme Sleepiness
• Cataplexia
• Others

By Product Channel:

• Central Nervous System Stimulants
• Sodium Oxybate
• Selective Serotonin Reuptake Inhibitor
• Tricyclic Antidepressants
• Others

What Will You Discover in the Report?

• An in-depth analysis of the Narcolepsy market across regions – North America, Latin America, Western Europe, Central and Eastern Europe, Asia Pacific, Middle East, and Africa.
• How the Narcolepsy market sales is expected to grow throughout the forecast period.
• How geopolitical policies and technological changes will affect the Narcolepsy market in near future
• Where the stakeholders should invest to generate higher profit margins
• How consumers (end-users) will reflect to the Narcolepsy industry during the forecast period
• Who are the Narcolepsy industry leaders and what are the key initiatives taken by them for long term growth

Analyst access with Bekryl Market Analysts

Purchasing of Narcolepsy market research report will give clients access to 120 minutes telephonic access with a research analyst. The duration for access to analysts will be based on the report subscription editions.

Global Small Joint Reconstructive Implants Market size is estimated to be valued over US$ 7,811 million in 2019, registering a CAGR of 5.9% between 2019 and 2028. Small joint replacement procedure has always been far from ideal positions, however, recent developments has made industry to be more agile with higher success rate. Procedural volumes in small joint implant market is driven by rising geriatric population group and product innovation.

Key Trends and Factors Driving Small Joint Reconstructive Implants Market Demand:

• A range of key developments were seen in the market in last few years. The trend is likely to be the same throughout the forecast period. Product development will continue to be the major trend in the industry. Race towards best products with high safety standards has led companies to spend heavily on R&D. Industry players are spending on product R&D to gain higher market traction. Recently, in July 2019, DJO Global announced the launch of AltiVate Reverse Short Stem – designed for reverse shoulder arthroplasty. On February 2019, Paragon 28 launched soft tissue fixation device for foot and ankle. As per the company, the product leverages titanium threaded implant for optimal fixation of soft tissue to bone. In 2018, Depuy Synthes launched DYNACORD suture to repair soft tissue injury.
• Few companies are expected to focus on enhancing distribution channel and opt for inorganic growth strategy, considering increasing market competition. Recently in February 2019, Colfax Corporation acquired DJO Global, Inc.

Global Small Joint Reconstructive Implants Market Size, Analysis across Segments:

• On the basis of product type, the industry revenue is analyzed across bone cements, shoulders, elbows, digits, ankles, and wrists. Among these, bone cements dominated the market with 47% market share, followed by shoulders. Elbows, digits, wrists and ankles contributed minimal share to the revenue. Bone cements will continue to register fastest growth during the forecast period.
• On the basis of material, the industry revenue is analyzed across metal and polymer. Among these, polymer formed the largest segment in 2018.
• On the basis of end-use, the revenue is analyzed across hospitals, ambulatory surgical centers, specialized clinics and others. 79% of the small joints implants procedure was carried out in hospitals in 2018. The trend is likely to be the same throughout the forecast period.

Global Small Joint Reconstructive Implants Market Size, Regional Analysis:

In 2018, North America accounted for the highest revenue share. Small joint reconstructive implants Industry players generated over US$ 2,872 million in 2018. The region is well equipped with state of art modern healthcare technology as well as best-in-class hospital infrastructure. Per capita spending in the region is relatively higher compared to the rest of the world. As a result, leading companies have higher focus on capitalizing the market in North America. While, the regional market is highly competitive, existing industry players have been able to generate good revenue share. These companies adopt long term distribution channels to ensure market presence in the region.

Western Europe small joint reconstructive implants market stands next to North America. Germany, UK and France collectively accounted for 73% market share in the region. While the region offers high market opportunity, intensifying cost and service pressures has led vendors to optimize distribution channel. Growth in the market is flat with CAGR of 3.1% between 2019 and 2028.

Asia Pacific small joint reconstructive implants market is the fastest growing region. Growth in the region is attributed to lower surgical costs. Moreover, funding through foreign investment has increased in the region since 2010. Planned investment in the region will bolster healthcare infrastructure.

Global Small Joint Reconstructive Implants Market Size, Competition Landscape:

Some of the key industry players covered in the report are:

• Zimmer Biomet Holdings Inc.
• Smith & Nephew plc
• DePuy Synthes Companies
• Integra LifeSciences Holdings Corporation
• DJO Global Inc.
• Exactech Inc.
• Stryker Corporation
• Orthofix Medical Inc.
• Wright Medical Group N.V.
• Arthrex Inc.
• Acumed LLC

Research Scope:

By Type:

• Bone Cements
• Shoulders
• Elbows
• Digits
• Ankles
• Wrists

By Material:

• Metal
• Polymers

By End-use:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

What Will You Discover in the Report?

• An in-depth analysis of the Small Joint Reconstructive Implants market across regions – North America, Latin America, Western Europe, Central and Eastern Europe, Asia Pacific, Middle East, and Africa.
• How the Small Joint Reconstructive Implants market sales is expected to grow throughout the forecast period?
• How geopolitical policies and technological changes will affect the Small Joint Reconstructive Implants market in near future
• Where the stakeholders should invest to generate higher profit margins
• How consumers (end-users) will reflect to the Small Joint Reconstructive Implants industry during the forecast period
• Who are the Small Joint Reconstructive Implants industry leaders and what are the key initiatives taken by them for long term growth?

Analyst access with Bekryl Market Analysts

Purchasing of Sleep Diagnostic Systems market research report will give clients access to 120-minute telephonic access with a research analyst. The duration for access to analysts will be based on the report subscription editions.